Effect of Acetazolamide on Sleep Related Breathing Disturbances in Patients With Respiratory Disease at Altitude
Status:
Completed
Trial end date:
2018-08-02
Target enrollment:
Participant gender:
Summary
In this trial, the investigators will evaluate the effect of acetazolamide (375 mg per day)
vs. placebo on sleep related breathing disturbances at altitude in patients with COPD.
Phase:
Phase 4
Details
Lead Sponsor:
University of Zurich
Collaborator:
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov